Back to Alerts
$ELVN
WATCHING
77
Score
$26.00
Price
+11.8%
Change
4.5x
Volume
📊 Score Breakdown
Options Activity
31/35
News Catalyst
15/25
Social Buzz
11/20
Price Confirmation
20/20
📊 Options Activity
Unusual Activity Detected
IV Spike
High Options Volume
📰 News (10 articles)
Assessing Enliven Therapeutics ELVN Valuation After Encouraging Phase 1b ENABLE Trial Data
Enliven Reports Positive Initial Phase 1b Data for ELVN-001 in CML and Outlines 2026 Clinical Milest
Enliven Therapeutics ELVN Evaluating Valuation After a Recent Share Price Rebound and Ongoing Clinic
💬 Social Buzz
Social Sentiment: 76% Bullish